Indirect treatment comparison of bevacizumab + interferon-?-2a vs tyrosine ... - UroToday Print
UroToday
... in first-line metastatic renal-cell carcinoma (mRCC) therapy. These targeted therapies are currently competing to be primary choice; hence, in the absence of direct head-to-head comparison, there is a need for valid indirect comparison assessment.

...